Metraipolis › archive › dc_fd570f49a10d
Comparison of the efficacy of low, moderate and standard doses of rituximab in the treatment of membranous nephropathy — Europe PMC PMID:41889528
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41889528
- DOI
- 10.3389/fmed.2026.1744264
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T19:57:33.413Z
- SHA-256 of the archived text
b0506656a60749c587c3a52631c5536a25ef2b0e8336ed60e23445a5d6929378- Stable URL of this page
https://metraipolis.com/documento/dc_fd570f49a10d
How to cite
Comparison of the efficacy of low, moderate and standard doses of rituximab in the treatment of membranous nephropathy — Europe PMC PMID:41889528 — Europe PMC (en), https://europepmc.org/article/MED/41889528 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd570f49a10d (Metraipolis archive dc_fd570f49a10d, sha256 b0506656a60749c587c3a52631c5536a25ef2b0e8336ed60e23445a5d6929378)
BibTeX
@misc{dcfd570f49a10d,
title = {Comparison of the efficacy of low, moderate and standard doses of rituximab in the treatment of membranous nephropathy — Europe PMC PMID:41889528},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41889528},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd570f49a10d; sha256 b0506656a60749c587c3a52631c5536a25ef2b0e8336ed60e23445a5d6929378},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41889528. Agents can read the archived copy with the MCP tool read_document.